Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AlloVir, Inc. - Common Stock (NQ: ALVR )

0.4498 -0.0267 (-5.60%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AlloVir, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
MarketBeat Week in Review – 7/10 - 7/14
As inflation moderates, Investors are optimistic for the second quarter earnings season and that optimism is evident in some of the top stories from this week 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus
Regulatory filings show Gilead Sciences' purchase of shares in AlloVir and Arcus. Strategic investments in the biotech sector are fairly common to boost growth. 
Via MarketBeat
Topics Retirement
Exposures Pension
BlackBerry, Micron And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. BlackBerry Limited (NYSE: BB) shares climbed 18.5% to $5.94 in pre-market... 
Via Benzinga
Why Shares of AlloVir Plummeted This Week
The clinical-stage biotech's shares fell after the company announced a stock sale. 
Via The Motley Fool
Why AlloVir Stock Is Diving Thursday
AlloVir Inc (NASDAQ: ALVR) shares are trading lower after the company priced a public offering of common stock. 
Via Benzinga
$11M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks... 
Via Benzinga
Mercury Systems And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Crude Oil Down Over 4%; Innovative Eyewear Shares Plummet
U.S. stocks traded mostly higher toward the end of trading, with the NASDAQ Composite gaining around 100 points on Thursday. The Dow traded down 0.03% to 33,942.78 while the NASDAQ rose 0.75% to... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Is AlloVir (ALVR) Stock Down 23% Today?
AlloVir (ALVR) stock is falling hard on Thursday after the company announced the pricing of a $75 million public share offering. 
Via InvestorPlace
Why AlloVir Stock Is Tumbling After Hours
AlloVir Inc (NASDAQ: ALVR) shares are trading lower in Wednesday's after-hours session after the company proposed a public offering. 
Via Benzinga
AlloVir: Q1 Earnings Insights
Via Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
Via Benzinga
Nasdaq Rises 70 Points; Aeglea BioTherapeutics Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 70 points on Thursday. The Dow traded down 0.11% to 33,912.98 while the NASDAQ rose 0.54% to 13,574.90. The S&P... 
Via Benzinga
Tesla (TSLA) Stock Slides After Second Downgrade This Week
Tesla (TSLA) stock is on the move Thursday after the company got hit with its second downgrade this week, despite increased price targets. 
Via InvestorPlace
US Stocks Lower Following Initial Jobless Claims Report
U.S. stocks traded lower this morning, with Nasdaq Composite dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.16% to 33,895.80 while the NASDAQ fell... 
Via Benzinga
Why Is Gulfport Energy (GPOR) Stock Down 8% Today?
Gulfport Energy (GPOR) stock is falling on Thursday after the company revealed details of a public share offering from certain investors. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Root Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 100.8% to $2.65 in pre-market trading after dropping 43% on Wednesday. 
Via Benzinga
AlloVir, DigitalOcean And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. AlloVir, Inc. (NASDAQ: ALVR) shares dipped 24.1% to $3.74 in pre-market... 
Via Benzinga
AlloVir Announces Pricing of Public Offering of Common Stock
From AlloVir, Inc.
Via Business Wire
AlloVir Announces Proposed Public Offering of Common Stock
From AlloVir, Inc.
Via Business Wire
Why Shares of AlloVir Jumped This Week
The company's lead therapy fared well in preventing infections for kidney transplant patients. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq. 
Via Benzinga
AlloVir Presents Positive Final Results From A Phase 2 Randomized, Placebo-Controlled Trial Evaluating Posoleucel Treatment of BK Infection in Kidney Transplant Recipients at the American Transplant Congress (ATC 2023)
From AlloVir, Inc.
Via Business Wire
AlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial Officer
From AlloVir
Via Business Wire
AlloVir Reports First Quarter 2023 Financial Results
From AlloVir
Via Business Wire
AlloVir to Present at the BofA Securities 2023 Health Care Conference
From AlloVir, Inc.
Via Business Wire
AlloVir's Posoleucel Achieves Non-Relapse Mortality Of 0% In Transplant Patients For Viral Infections
AlloVir Inc (NASDAQ: ALVR) announced the presentation of long-term, follow-up data from the Phase 2 study of posoleucel to prevent infections from six viruses in allogeneic hematopoietic cell... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.